Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

4.2K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
4.2K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

9.7K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
9.7K
Drug Delivery: Overview01:16

Drug Delivery: Overview

879
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
879
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

1.8K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.8K
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

1.7K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.7K
Introduction To Health Care Delivery System01:18

Introduction To Health Care Delivery System

4.2K
The healthcare system is constantly changing and complex. Various services are available from different healthcare providers, but gaining access to these services has become challenging for people with limited healthcare insurance. Uninsured people present a challenge to healthcare because they frequently postpone or forego treatment.
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mediation by atherogenic index of plasma of the association between body roundness index and cognitive impairment in older Chinese people: an analysis using health check-up data.

Frontiers in public health·2026
Same author

p38β/MAPK11 Deficiency Exacerbates Cardiac Structural and Electrophysiological Remodeling and Contributes to Immune Dysregulation in the Aging Heart.

bioRxiv : the preprint server for biology·2026
Same author

Analytical modeling for suction cup designs for skin-interfaced wearable devices.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Impact of preoperative lumbar paraspinal muscle quality on the prognosis of open pedicle screw fixation for thoracolumbar fractures.

Frontiers in surgery·2026
Same author

Rim enhancement on MRI predicts long-term outcomes in extruded/migrated lumbar disc herniation managed with an inflammation-preserving protocol: a 6-year prospective cohort study.

Frontiers in medicine·2026
Same author

Centrifugal microfluidics for rapid target analyte quantification in airborne bioaerosols.

Lab on a chip·2026

Related Experiment Video

Updated: Feb 7, 2026

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform
08:02

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform

Published on: November 7, 2013

13.4K

Multiscale 3D microfluidic platform for intraorganoid delivery.

Colin Franz1,2,3, Maria Quezada1,4,5,6, Jamin Lee7

  • 1Regenerative Neurorehabilitation Laboratory, Shirley Ryan Ability Lab, Chicago, IL 60611, USA.

Research Square
|February 6, 2026
PubMed
Summary
This summary is machine-generated.

Researchers developed a 3D microfluidic platform to deliver biomolecules deep within neural organoids. This technology improves control over the organoid microenvironment, enhancing tissue integrity and enabling advanced developmental studies.

More Related Videos

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
10:42

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform

Published on: June 15, 2021

5.6K
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

25.4K

Related Experiment Videos

Last Updated: Feb 7, 2026

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform
08:02

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform

Published on: November 7, 2013

13.4K
Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
10:42

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform

Published on: June 15, 2021

5.6K
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

25.4K

Area of Science:

  • Neuroscience
  • Bioengineering
  • Developmental Biology

Background:

  • Neural organoids are valuable 3D models for studying human development and disease.
  • Current neural organoids lack efficient internal transport systems, limiting nutrient and oxygen diffusion to deep tissues.
  • Microfluidic systems offer potential for precise delivery but integrating them into organoids without disrupting growth is difficult.

Purpose of the Study:

  • To develop a multiscale 3D microfluidic platform for controlled intra-organoid delivery.
  • To overcome limitations in perfusing deep regions of neural organoids.
  • To enable site-specific interrogation of organoid microenvironments.

Main Methods:

  • Embedding lithographically defined, thread-like microchannels into growing neural organoids.
  • Utilizing a nanoporous interface for controlled diffusive transport.
  • Demonstrating delivery of dyes, morphogens, and MRI contrast agents with high spatial and temporal precision.

Main Results:

  • Achieved controlled diffusive transport of biomolecules with ~100 um spatial resolution and ~400 um depth.
  • Demonstrated minute-scale temporal precision for delivery.
  • Observed reduced apoptosis and improved neural tissue integrity with growth factor delivery.

Conclusions:

  • The developed platform enables precise, site-specific delivery within neural organoids.
  • This technology enhances organoid viability and structural organization.
  • It provides a robust tool for advancing research on organoid microenvironments, maturation, and disease modeling.